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Developing multifunctional photosensitizers (PSs) is needed to eﬀectively simplify cancer treatment, but it
remains a big challenge. Here, two red-emitting AIE-active, donor–acceptor (D–A) PSs with small DEST and
their AIE nanoparticles, are rationally designed and synthesized. The PS1 NPs exhibit bright red-emission
with high quantum yield, appropriate 1O2 generation ability and good biocompatibility. More importantly,
PS1 NPs can strongly light up the cytoplasm by gently shaking the cells for only 5 s at room temperature,
indicating ultrafast staining and mild incubation conditions. In vitro and in vivo cell tracing demonstrate
that PS1 NPs can track cells over 14 days, and eﬀectively inhibit tumor growth upon irradiation. To the
best of our knowledge, this work is the ﬁrst example of a PS that integrates image-guided PDT, ultrafast
staining and long-term tracing functions, demonstrating the “all-in-one” concept which oﬀers great
advantages for potential clinical applications.Introduction
Image-guided photodynamic therapy (PDT) has recently gained
increasing attention. This technique simultaneously achieves
real-time molecular diagnosis and concurrent light-triggered
therapy, and has surpassed traditional surgery, such as radio-
therapy and chemotherapy.1–8 Noninvasive uorescence
imaging has emerged as a very powerful tool for visualizing
clinical diagnostics and for biological research.9–14 Unfortu-
nately, discontinuous and short-term cellular tracing is unable
to provide continuous real-time dynamic information, thereby
limiting the insights into a variety of complex biological
processes.15–21 Long incubation times and harsh incubation
conditions are critical barriers for cellular uorescence imaginganobioanalysis at Universities of Jilin
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f Chemistry 2020in clinical applications.22–25 Cancer treatments mainly include
three essential steps: ultrafast staining, therapy, and long-term
tracing. The former two play important roles for the discovery
and excision of tumors, and the last is to further monitor the
metastasis of residual tumor.15,21 The current scope of photo-
sensitizers (PSs) is far from ideal, and until now, only a few PSs
can achieve partial procedures, whereas there are no reports on
simultaneous multiple applications, namely: (i) image-guided
PDT, (ii) ultrafast staining and (iii) long-term tracking. Is it
possible to design a single “all-in-one” PS that embraces all the
above functions at the same time?
PSs with eﬃcient generation of singlet oxygen (1O2) and
bright red-emission are crucial to realize imaging-guided PDT.26
An eﬀective strategy to improve the eﬃciency of 1O2 generation
is to accelerate the intersystem crossing (ISC) and to reduce
DEST (the energy gap between S1 and T1 states).27–31 A small DEST
is obtained by constructing a conjugated donor–acceptor (D–A)
structure, which is benecial for strong intramolecular charge
transfer (ICT) with eﬃcient separation of the highest occupied
molecular orbital (HOMO) and lowest unoccupied molecular
orbital (LUMO), leading to red-shied emission.32–35 Red emis-
sion is important because of its minimized autouorescence
interference, increased penetration depth, and less damage to
tissue.36–38 However, traditional organic molecules tend to form
aggregates in aqueous media, for example by p–p stacking,
which directly leads to reduced 1O2 production, non-radiative
pathways and quenched uorescence.27,39–41
To overcome this challenge, the concept of aggregation-
induced emission (AIE) has been exploited, notably by Tang'sChem. Sci., 2020, 11, 2369–2374 | 2369
Fig. 2 (A) HOMO and LUMO distributions of PS1 and PS2 based on
TD-DFT. UV-vis and emission spectroscopies of (B) PS1 and (C) PS2 in
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View Article Onlinegroup.42–45 A series of AIEgen-based PSs have been reported to
improve both the uorescence intensity and the 1O2 production
ability in the aggregated state, due to the restriction of intra-
molecular motions (RIMs) which lead to energy dissipation.46–54
Recently, our group obtained three red-emitting AIEgen nano-
particles (NPs) with higher brightness, enhanced 1O2 genera-
tion, and better biocompatibility compared to the pure
iridium(III) complexes.55 These precedents make AIE NPs with
purely organic D–A units particularly suitable as smart PSs to
successfully obtain an “all-in-one” (image-guided PDT, ultrafast
staining and long-term tracing) system.
In this contribution new PSs are designed and easily
synthesized in high yield via a three-bladed propeller-like tri-
phenylamine (TPA) as the strong donor and the dicyanovinyl
(DC) groups as the acceptor, in which TPA also acts as a rotor to
realize AIE.56 The two red-emitting AIE D–A and D–A–D mole-
cules are PS1 and PS2 (Fig. 1A) and their corresponding
polymer-encapsulated NPs are PS1 NPs and PS2 NPs. PS1 NPs
possess bright red-emission, a large Stokes shi, appropriate
1O2 generation ability, good biocompatibility and excellent
image-guided PDT activity. More importantly, PS1 NPs achieve
ultrafast staining of cells in only 5 s at room temperature, with
excellent long-term imaging of more than 14 days in vitro and in
vivo.DMSO, DMSO/water (v/v) ¼ 1/9, and the corresponding PS NPs in
water (lex ¼ 488 nm), insert: the ﬂuorescent image of PSs and their
NPs under 365 nm UV light. (D) The decomposition rates of ICG with
diﬀerent PSs under white irradiation (20 mW cm2). (E) Size
measurement of diﬀerent PSs in 14 days, insert: the TEM images of (a)
PS1 NPs and (b) PS2 NPs.Results and discussion
To gain an insight into the molecular properties of PS1 and PS2,
time-dependent density theory (TD-DFT) calculations were
performed (Fig. 2A). The HOMOs are mainly localized on TPA
units, whereas the LUMOs are located on DC units, with
signicant HOMO–LUMO separation. The energy gap between
the HOMO and LUMO of PS1 and PS2 is 2.449 and 2.425 eV,
respectively. These relatively narrow band gaps induce the red-
shied absorption. Furthermore, the additional triphenylamine
unit in PS2 results in a slight reduction of DEST (PS2 0.204 eV;Fig. 1 (A) Structural formulas of PS1 and PS2. (B) Schematic illustration
of PS1 NPs as PSs for “all-in-one” PDT.
2370 | Chem. Sci., 2020, 11, 2369–2374PS1 0.229 eV), owing to a smaller spatial overlap of the Frontier
orbitals. The small DEST values of PS1 and PS2 are benecial for
ISC, which will facilitate highly eﬃcient 1O2 generation.29
The photophysical properties of the PSs were investigated by
absorption and photoluminescence (PL) spectroscopy. In
Fig. 2B and C the absorption bands at about 210–315 nm are
assigned to the p–p* transition of the conjugated backbone.
The bands located in the 380–600 nm region belong to the
intense ICT process between the D–A units. The absorption
band covers most of the visible light range, which is benecial
for matching the white light spectrum.28 In Fig. S9 (ESI†), both
PS1 and PS2 show negligible uorescence in DMSO, because the
rotational motions of the triphenylamine moieties increase the
dissipation of energy. However, the PL intensities of PS1 and
PS2 gradually increase upon raising the water content, when
intramolecular rotation is restricted by the formation of aggre-
gates, revealing a typical AIE eﬀect. Compared with PS1 (lmax
660 nm) and PS2 (645 nm), their NPs show similar emission
peaks but with signicantly enhanced intensities. The PL
intensities of PS1NPs and PS2NPs are 6.9 and 2.86 times higher
than those of PS1 and PS2, respectively, with PS1 NPs 2.9 times
higher than PS2 NPs in the same conditions. The uorescence
spectra of these AIE NPs extend into the near-infrared region,
and they exhibit a large Stokes shi which can eliminate
interference from the background. These factors are favorableThis journal is © The Royal Society of Chemistry 2020
Fig. 3 Viability of HeLa cells treated with (A) PS1 NPs and (B) PS2 NPs
with or without white light (20 mW cm2, 60 min). (C) CLSM images of
HeLa cells after incubationwith PS1NPs (3 mgmL1) for diﬀerent times.
(D) Long-term cell tracing images of the PS1 NPs (20 mg mL1) at 37 C
for 6 h and then subcultured for a diﬀerent number of days. Scale bar¼
20 mm for all images.
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View Article Onlinefor bioimaging. The uorescence quantum yields (QYs) of PS1
NPs and PS2 NPs in water are 40% and 32%, respectively, which
are much higher than PS1 and PS2 (16% and 13%, respectively)
in DMSO-water mixtures. Compared with tetraphenylethylene
(TPE),41 in the present work TPA with stronger electron donating
ability promoted a red-shi in the absorption and emission of
the PSs. This shi is benecial for eﬃcient biological applica-
tions, such as image-guided PDT, ultrafast staining and long-
term tracking. These results conrm that the AIE NPs possess
favourable photophysical properties.
Photosensitized 1O2 generation plays an important role in
PDT.57 To evaluate the 1O2 generation ability of PS1, PS2 and
their NPs, indocyanine green (ICG) was used as an indicator. No
obvious changes of absorbance were observed in three control
groups: (i) ICG + irradiation, (ii) PSs + irradiation, and (iii) ICG +
PSs without irradiation (ESI, Fig. S14–S16†), verifying that all
the PSs show good photostability.58 As expected, upon irradia-
tion of ICG (5 mg mL1) solutions in the presence of PS1, PS2
and their NPs (30 mg mL1), the absorption peak of ICG at
790 nm gradually decreases in intensity (Fig. 2D; ESI, Fig. S17†),
indicating that the PSs possess 1O2 generation ability. In
Fig. S18 (ESI†) all the PSs follow a rst-order 1O2 generation
behavior. The slopes can be ordered as PS1 (1.45  103) < PS2
(1.88  103) < PS1 NPs (4.36  103) < PS2 NPs (5.32  103).
The slopes of the kinetic decays of PS1 NPs and PS2NPs are 3.01
and 2.83 times higher than for PS1 and PS2, respectively. A
steeper slope represents a quicker decay rate of ICG and
increased ability to generate 1O2. The
1O2 quantum yields of
PS1, PS2, PS1 NPs and PS2 NPs are 38%, 43%, 67% and 76%
with methylene blue (MB) as the reference (FD ¼ 52% in
MeCN). Overall, these NPs generate 1O2 very eﬀectively and they
possess great potential as PSs for PDT applications.
In addition, the morphology, size and stability of these NPs
are important premises for biomedical applications. PS1 NPs
and PS2 NPs are spherical and possess uniform sizes of 52 nm
and 46 nm, respectively (Fig. 2E, insert). The corresponding
hydrodynamic sizes are 82 nm and 79 nm, respectively (ESI,
Fig. S19†). In addition, the diameters of PS1 NPs and PS2 NPs
are stable within 14 days in water (Fig. 2E). Meanwhile, the
uorescence and absorbance intensity of PS1 NPs and PS2 NPs
both retain more than 80% and 98%, respectively, of their
initial values aer 7 days (ESI, Fig. S11 and S12†), indicating
that these NPs have excellent optical stability. The combination
of spherical morphology, suitable size, superior physical
stability and excellent photostability suggest that these NPs are
suitable for the ensuing biological applications.
In vitro cytotoxicity of all the PSs toward HeLa cells was
measured by MTT colorimetric assay.59 The cells retained >95%
viability aer incubation with PS1 NPs and PS2 NPs for 24 h
(Fig. 3A and B) indicating good cytocompatibility. Under white-
light irradiation PS1 NPs and PS2 NPs have dose-dependent
cytotoxicity. The half-maximal inhibitory concentration (IC50)
is in the sequence PS1 NPs (5.72 mg mL1) > PS2 NPs (4.31 mg
mL1). In contrast, PS1 and PS2 exhibit some dark cytotoxicity
and low phototoxicity (ESI, Fig. S20†). The same results were
observed in A549 cells and MDA-MB-231 cells (ESI, Fig. S21†).
Intracellular 1O2 generation of PS2 NPs was further investigatedThis journal is © The Royal Society of Chemistry 2020by using DCFH-DA as indicator. In Fig. S23 (ESI†) aer irradi-
ation the green emission from PS2 NPs is evidently brighter
than that from PS2, indicating the enhanced 1O2 generation
ability of the nanoparticle formulation. Moreover, the anti-
cancer eﬃciencies of PS1, PS2 and their NPs were examined by
live/dead staining techniques (ESI, Fig. S22†). Under light irra-
diation, negligible green uorescence has been observed which
indicates that the cancer cells are completely killed. The
proportion of dead cells in the group of PS1 NPs and PS2 NPs
under irradiation was much higher than with PS1 and PS2,
which agrees with the above MTT results.
The bright uorescence emission, large Stokes shi, favor-
able stability, and good cytocompatibility of PS1 NPs and PS2
NPs inspired us to conduct further investigation in their intra-
cellular imaging behavior. HeLa cells were incubated with PS1
NPs and PS2 NPs (3 mg mL1) for diﬀerent times as depicted in
Fig. 3C and S28 (ESI†). Bright red emission was observed from
the cells treated with PS1 NPs, whereas negligible emission was
observed with PS2 NPs. The PS1 NPs are more suitable for
ultrafast staining, because as described above that PS1 NPs
possess brighter red emission and higher uorescence
quantum yield (40%) than PS2 NPs. The cytoplasm was brightly
emissive aer simply shaking the cell incubate with PS1 NPs for
5 s at room temperature, demonstrating its ultrafast staining on
the timescale of a few seconds. More strikingly, the cellular
interior was lit up by incubation with 0.5 mg mL1 of PS1 NPs
(ESI, Fig. S24†). These results strongly validate that the PS1 NPs
could be applied for ultrafast staining.
The applications of the PS1NPs and PS2NPs for in vitro long-
term cellular tracing were investigated. As shown in Fig. 3D and
S31 (ESI†), the internal cells were stained by PS1 NPs and PS2
NPs with bright red uorescence in their initial stages which
gradually decreased with time. Obviously, the cell tracking
ability of PS1 NPs is better than that of PS2 NPs, which could beChem. Sci., 2020, 11, 2369–2374 | 2371
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View Article Onlineattributed to the brighter red emission of PS1NPs than PS2NPs.
Negligible change in cell morphology was observed from day 1
to day 15 during long-term cell tracing. This indicates that there
are no cytotoxicity eﬀects for long-term cell tracing with PS1 and
PS2NPs. Under the same conditions, ow cytometry results also
demonstrate that both PS1NPs and PS2 NPs have a tendency to
accumulate in HeLa cells aer 15 days incubation (ESI,
Fig. S33†). Therefore, the PS1 NPs could perform as a promising
long-term tracing probe.
Motivated by the excellent performance in vitro, PS1 NPs
were further evaluated in vivo with U14 tumor-bearing mice. In
Fig. 4A, obvious uorescent signals were obtained from the site
injected with PS1 NPs, indicating good in vivo imaging. With
increasing time, the uorescence intensity gradually decreased,
but still retained 42% of the initial intensity aer 14 days
(Fig. 4B), indicating the excellent in vivo long-term tracing
ability of PS1NPs. Aer PDT treatment, faint uorescence could
be observed, suggesting high PDT eﬃcacy of PS1 NPs. Simul-
taneously, in Fig. 4C, in the control groups, the relative tumor
volumes increased by 10–13 times aer 14 days, implying that
treatment only by irradiation or by PS1 NPs, has negligible
inuence on tumor growth. As expected, tumor volume in the
experimental group showed a signicant reduction, conrming
the good anticancer eﬀect of PS1 NPs under white-light irradi-
ation. Negligible changes of body weight were observed aer
various treatments (ESI, Fig. S34D†) indicating the low systemicFig. 4 (A) Time-dependent in vivo ﬂuorescence images of U14 tumor-
bearing mice after intratumoral injection with PS1 NPs (100 mg mL1,
100 mL) or with PS1 NPs + white light (200 mW cm2, 20 min). (B)
Harvested tumors from various groups treated. (C) Fluorescence
intensity of U14 tumor-bearing mice in diﬀerent mice groups. (D)
Tumor volume measurement for diﬀerent treatments of mice (***P <
0.001, n ¼ 4 per group, PDT vs. other groups). (E) H&E staining images
of tumor slices from each groups. Scale bars: 100 mm. (a) With saline,
(b) with saline and light, (c) with PS1NPs, (d) with PS1NPs and light (100
mg mL1, 100 mL), white light (200 mW cm2, 20 min).
2372 | Chem. Sci., 2020, 11, 2369–2374toxicity of PS1 NPs. The biosafety of PS1 NPs was further eval-
uated by hematoxylin and eosin (H&E) staining of major organs.
No pathological changes were found in the major organs of the
four groups. These results reveal that PS1 NPs are excellent
candidates for in vivo long-term tracing and image-guided PDT.Conclusions
In summary, we have successfully constructed for the rst time
a single PS to simultaneously achieve image-guided PDT,
ultrafast staining and long-term tracing. Two red-emitting AIE-
active D–A organic molecules and their NPs, were rationally
designed and synthesized. The small DEST increases the inter-
system crossing (ISC) process, leading to eﬀective 1O2 genera-
tion for the two PSs. The construction of nanoparticles further
improves the uorescence intensity and the 1O2 production
ability. Especially the PS1 NPs are ideal for biological applica-
tions owing to the following advantages: bright red emission,
large Stokes shi, high uorescence quantum yield (40%),
appropriate 1O2 generation ability, good biocompatibility, and
excellent image-guided PDT activity. More importantly, PS1 NPs
can stain cells in only 5 s at room temperature, and they display
excellent long-term imaging for more than 14 days in vitro and
in vivo. This work successfully achieves a smart AIE PS with
image-guided PDT, ultrafast staining and long-term tracing
functions. This prototype example of “all-in-one” PS NPs should
stimulate the design and development of new multifunctional
PSs for potential clinical applications.Ethical statement
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